MARY HARTMAN: Open Payments
NPI 1609572056 · SAN MARCOS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$749 in 45 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $136 · 2025 $749
Food & beverage: $749
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 16 | $176 |
| Novo Nordisk Inc | 4 | $86 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $77 |
| Lilly USA, LLC | 4 | $69 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $60 |
| Axsome Therapeutics, Inc. | 2 | $54 |
| Corcept Therapeutics | 2 | $40 |
| GlaxoSmithKline, LLC. | 2 | $32 |
| Medtronic, Inc. | 2 | $31 |
| Janssen Pharmaceuticals, Inc | 1 | $20 |
Products named: NURTEC ODT, JARDIANCE, Kerendia, Ozempic, PREVNAR 20, Korlym, ZEPBOUND, Symbravo.
Industry payments across TX — which companies pay providers there.
